Silicon Labs (SLAB)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-04
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-04
QuarterlyIQ Insights · SLAB
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 3 valuation methods, at three horizons. As of 2026-09-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $221 SLAB trades at 8.7× p/s, in line with its 8.3× p/s peer median — but our blended $100 fair value sits well below the price. We hold it with medium confidence: its earnings are too depressed to value on P/E (we anchor on sales instead). The flat-multiple read looks rich, but earnings are inflecting up — trailing growth is accelerating and forward estimates confirm — so we've softened our read rather than brand an accelerating name expensive. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer P/E | 12M | $102.27 | 26.2 | 3.90 | ntm analyst | medium |
| Peer P/S | 12M | $209.39 | 8.3 | 25.31 | TTM | medium |
| triangulated | 12M | $47.19 | 49.4 | 0.96 | Triangulated | medium |
| Peer P/E | 3Y | $145.90 | 26.2 | 5.57 | Hist. CAGR(prov.) | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
| Peer P/S | 3Y | $343.55 | 8.3 | 41.53 | Analyst | medium |
| Peer P/E | 5Y | $192.95 | 26.2 | 7.37 | Hist. CAGR(prov.) | medium |
| Peer P/S | 5Y | $454.35 | 8.3 | 54.92 | Analyst | medium |